Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 


Online Report Subscribers, Click Here
Pricing and Ordering Information

European Markets for Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products
Report #A217 - May 2009
277 Pages – 94 Exhibits
12 Company Profiles


In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union.

In 2008, the combined European market for electrocardiography products and cardiovascular disease-related in vitro diagnostic near-patient testing products was valued at approximately $556.4 million. Among France, Germany, Italy, Spain, and the U.K., the largest country market was Germany, with sales of approximately $213.7 million (38.4% of the total market value). The German market was followed by France with $191.0 million in sales (34.3%), the U.K. with $68.7 million (12.4%), Italy with $47.4 million (8.5%), and Spain with $35.6 million (6.4%)

This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the fields of electrocardiography and in vitro diagnostic near-patient testing.

Covered topics in this report include cardiovascular disease-related in vitro diagnostic near-patient testing products available in Europe—including those for the assessment of cardiac markers, cholesterol/lipid levels, and coagulation status—along with test volumes, sales volumes, and competitive analyses; cardiovascular disease/disorder statistics for Europe; discussions of the healthcare markets of France, Germany, Italy, Spain, and the U.K.; and electrocardiography products, procedure volumes, sales volumes, and competitor comparisons.

Ordering Information

Title

 Report# Publication
Date		 List Price

European Markets for Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products

A217

 May 2009

$4,850
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i.       Electrocardiography Products Market

ii.       Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient  Testing Products Market

a.   In Vitro Diagnostic Near-Patient Cardiac Markers Testing Products Segment

b.   In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products Segment

c.    In Vitro Diagnostic Near-Patient Coagulation Testing Products Segment

iii.      Methodology

 

Exhibit ES-1:    Europe, Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013

Exhibit ES-2:    Europe, Electrocardiography and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013

Exhibit ES-3:    Europe, Electrocardiography Products, Combined Market Forecast, 2008-2013

Exhibit ES-4:    Europe, Electrocardiography Products, Market Forecast, by Country, 2008-2013

Exhibit ES-5:    Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013

Exhibit ES-6:    Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013

Exhibit ES-7:    Europe, In Vitro Diagnostic Near-Patient Cardiac Marker  Testing Products, Combined Market Forecast, 2008-2013

Exhibit ES-8:    Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, by Country, 2008-2013

Exhibit ES-9:    Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Combined Market Forecast, 2008-2013

Exhibit ES-10:  Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, by Country, 2008-2013

Exhibit ES-11:  Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Combined Market Forecast, 2008-2013

Exhibit ES-12:  Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, by Country, 2008-2013

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      European Union Population Statistics Comparison for the Years 1998, 2008, and 2018

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

 

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

2.1 The Heart and Circulatory System

2.1.1 The Cardiac Conduction System

2.1.2 The Heart Valves

2.2 Diseases/Disorders Involving the Vasculature

2.2.1 Coronary Heart Disease

2.2.1.1 Atherosclerosis

2.2.1.1.1 Description

2.2.1.1.2 Statistics

2.2.1.2 Angina Pectoris

2.2.1.2.1 Description

2.2.1.2.2 Statistics

2.2.1.3 Myocardial Infarction

2.2.1.3.1 Description

2.2.1.3.2 Statistics

2.2.2 Hypertension

2.2.2.1 Description

2.2.2.1.1 Systolic and Diastolic Pressures

2.2.2.1.2 Prehypertension

2.2.2.2 Statistics

2.2.3 Aneurysm

2.2.3.1 Description

2.2.3.2 Statistics

2.2.4 Stroke

2.2.4.1 Description

2.2.4.2 Statistics

2.3 Diseases/Disorders Involving the Cardiac Conduction System

2.3.1 Types

2.3.1.1 Bradycardia

2.3.1.1.1 Description

2.3.1.2 Sick Sinus Syndrome

2.3.1.2.1 Description

2.3.1.3 Heart Block

2.3.1.3.1 Description

2.3.1.4 Atrial Fibrillation

2.3.1.4.1 Description

2.3.1.5 Tachycardia

2.3.1.5.1 Description

2.3.1.6 Ventricular Fibrillation

2.3.1.6.1 Description

2.3.2 Statistics

2.4 Diseases/Disorders Involving the Myocardium

2.4.1 Heart Defects

2.4.1.1 Description

2.4.1.2 Statistics

2.4.2 Heart Failure

2.4.2.1 Description

2.2.4.2 Statistics

2.4.3 Rheumatic Fever/Rheumatic Heart Disease

2.4.3.1 Description

2.4.3.2 Statistics

2.4.4 Heart Valve Disorders

2.4.4.1 Types

2.4.4.1.1 Valvular Stenosis

2.4.4.1.1.1 Description

2.4.4.1.2 Valvular Regurgitation

2.4.4.1.2.1 Description

2.4.4.1.3 Valve Prolapse

2.4.4.1.3.1 Description

2.4.4.2 Statistics

 

Exhibit 2-1:      Cross-Section Diagram of the Heart

Exhibit 2-2:      Cross-Section Diagram of the Heart Valves

Exhibit 2-3:      Men, Number of Deaths due to Cardiovascular Disease, Selected European Countries

Exhibit 2-4:      Women, Number of Deaths due to Cardiovascular Disease, Selected European Countries

Exhibit 2-5:      Total Cholesterol Levels in Men, Selected European Countries, 2005 and 2010

Exhibit 2-6:      Total Cholesterol Levels in Women, Selected European Countries, 2005 and 2010

Exhibit 2-7:      Europe, Atherosclerosis Prevalence, by Country

Exhibit 2-8:      Standard Angina Pectoris Classification

Exhibit 2-9:      Europe, Coronary Events Incidence Rates, Selected MONICA Project Populations, by Gender Group

Exhibit 2-10:    Europe, Myocardial Infarction Prevalence, by Country

Exhibit 2-11:    Europe, Systolic Blood Pressure Levels, Selected MONICA Project Populations, by Gender Group

Exhibit 2-12:    Mean Systolic Blood Pressure Levels in Men, Selected European Countries, 2005 and 2010

Exhibit 2-13:    Mean Systolic Blood Pressure Levels in Women, Selected European Countries 2005 and 2010

Exhibit 2-14:    Europe, Hypertension Prevalence, by Country

Exhibit 2-15:    Europe, Aneurysm Prevalence, by Country

Exhibit 2-16:    Europe, Stroke Disability and Mortality, By Selected Country

Exhibit 2-17:    Europe, Stroke Prevalence, by Country

Exhibit 2-18:    Europe, Cardiac Dysrhythmia Prevalence, by Country

Exhibit 2-19:    Congenital Heart Defects, Estimated Number of Simple and Complex Cases in the United Kingdom, 2000 and 2010

Exhibit 2-20:    United Kingdom, Heart Failure Prevalence, Selected Study Data

Exhibit 2-21:    Europe, Heart Failure Prevalence, by Country

Exhibit 2-22:    Rheumatic Heart Disease, Estimated Number of Reported Cases, Selected Countries/Regions

Exhibit 2-23:    Rheumatic Heart Disease Mortality, Selected European Countries

Exhibit 2-24:    Euro Heart Survey on Valvular Heart Disease Patient Population, Native Heart Valve Disorders, by Type

Exhibit 2-25:    Europe, Heart Valve Disorder Prevalence, by Country

 

3. ELECTOCARDIOGRAPHY PRODUCTS

3.1 Types of Electrocardiography Procedures

3.1.1 Resting Electrocardiography

3.1.2 Exercise/Stress Electrocardiography

3.1.3 Holter Monitoring

3.1.4 Event Monitoring

3.2 Electrocardiography, Procedure Volumes

3.3 Electrocardiography Systems, Market Analysis

3.3.1 Products

3.3.2 Market Forecast

3.3.3 Competitors

 

Exhibit 3-1:      Normal Electrocardiogram Trace

Exhibit 3-2:      Europe, Electrocardiography, Combined Procedure Volumes Forecast, 2008-2013

Exhibit 3-3:      Europe, Electrocardiography, Procedure Volumes Forecast, by Country, 2008-2013

Exhibit 3-4:      2009, Selected Electrocardiography Systems

Exhibit 3-5:      Europe, Electrocardiography Products, Combined Market Forecast, 2008-2013

Exhibit 3-6:      Europe, Electrocardiography Products, Market Forecast, by Country, 2008-2013

Exhibit 3-7:      France, Electrocardiography Products, Market Forecast, 2008-2013

Exhibit 3-8:      Germany, Electrocardiography Products, Market Forecast, 2008-2013

Exhibit 3-9:      Italy, Electrocardiography Products, Market Forecast, 2008-2013

Exhibit 3-10:    Spain, Electrocardiography Products, Market Forecast, 2008-2013

Exhibit 3-11:    United Kingdom, Electrocardiography Products, Market Forecast, 2008-2013

Exhibit 3-12:    2008, Europe, Electrocardiography Products Market, Share by Supplier

 

4. CARDIOVASCULAR DISEASE-RELATED IN VITRO DIAGNOSTIC NEAR-PATIENT TESTING PRODUCTS

4.1 In Vitro Diagnostic Near-Patient Testing for Cardiac Markers

4.1.1 Types of Tests

4.1.1.1 Creatine Kinase-MB

4.1.1.2 Myoglobin

4.1.1.3 Troponin-I and Troponin-T

4.1.1.4 Natriuretic Peptides

4.1.2 In Vitro Diagnostic Near-Patient Cardiac Marker Assessment, Test Volumes Forecast

4.1.3 In Vitro Diagnostic Near-Patient Cardiac Marker Testing Devices, Market Analysis

4.1.3.1 Products

4.1.3.2 Market Forecast

4.1.3.3 Competitors

4.2 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing

4.2.1 Types of Tests

4.2.1.1 Total Cholesterol

4.2.1.2 Low-Density Lipoprotein

4.2.1.3 High-Density Lipoprotein

4.2.1.4 Triglycerides

4.2.2 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Assessment, Test Volumes Forecast

4.2.3 In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Devices, Market Analysis

4.2.3.1 Products

4.2.3.2 Market Forecast

4.2.3.3 Competitors

4.3 In Vitro Diagnostic Near-Patient Coagulation Testing

4.3.1 Types of Tests

4.3.1.1 Activated Clotting Time

4.3.1.2 Activated Partial Thromboplastin Time

4.3.1.3 Bleeding Time

4.3.1.4 Prothrombin Time

4.3.1.5 Thrombin Clotting Time

4.3.1.6 Platelet Count/Function Determination

4.3.2 In Vitro Diagnostic Near-Patient Coagulation Assessment, Test Volumes Forecast

4.3.3 In Vitro Diagnostic Near-Patient Coagulation Testing Devices, Market Analysis

4.3.3.1 Products

4.3.3.2 Market Forecast

4.3.3.3 Competitors

4.4 Combined Market for Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products

 

Exhibit 4-1:      In Vitro Diagnostic Cardiac Marker Testing, Selected Applications

Exhibit 4-2:      Medical Conditions Associated with Elevated Natriuretic Peptide Levels

Exhibit 4-3:      Selected Investigated Clinical Applications or Heart Failure-Related Natriuretic Peptide Testing

Exhibit 4-4:      Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Assessment, Combined Test Volumes Forecast, 2008-2013

Exhibit 4-5:      Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Test Volumes, by Country, 2008-2013

Exhibit 4-6:      2009, Selected In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products

Exhibit 4-7:      Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Combined Market Forecast, 2008-2013

Exhibit 4-8:      Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, by Country, 2008-2013

Exhibit 4-9:      France, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013

Exhibit 4-10:    Germany, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013

Exhibit 4-11:    Italy, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013

Exhibit 4-12:    Spain, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013

Exhibit 4-13:    United Kingdom, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products, Market Forecast, 2008-2013

Exhibit 4-14:    2008, Europe, In Vitro Diagnostic Near-Patient Cardiac Marker Testing Products Market, Share by Supplier

Exhibit 4-15:    Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Assessment, Combined Test Volumes Forecast, 2008-2013

Exhibit 4-16:    Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Test Volumes, by Country, 2008-2013

Exhibit 4-17:    2009, Selected In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products

Exhibit 4-18:    Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Combined Market Forecast, 2008-2013

Exhibit 4-19:    Europe, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, by Country, 2008-2013

Exhibit 4-20:    France, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013

Exhibit 4-21:    Germany, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013

Exhibit 4-22:    Italy, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013

Exhibit 4-23:    Spain, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013

Exhibit 4-24:    United Kingdom, In Vitro Diagnostic Near-Patient Cholesterol/Lipid Testing Products, Market Forecast, 2008-2013

Exhibit 4-25:    2008, Europe, In Vitro Diagnostic Near-Patient Cholesterol/ Lipid Testing Products Market, Share by Supplier

Exhibit 4-26:    Europe, In Vitro Diagnostic Near-Patient Coagulation Assessment, Combined Test Volumes Forecast, 2008-2013  4-54

Exhibit 4-27:    Europe, In Vitro Diagnostic Near-Patient Coagulation Test Volumes, by Country, 2008-2013

Exhibit 4-28:    2009, Selected In Vitro Diagnostic Near-Patient Coagulation Testing Products

Exhibit 4-29:    Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Combined Market Forecast, 2008-2013

Exhibit 4-30:    Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, by Country, 2008-2013

Exhibit 4-31:    France, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013

Exhibit 4-32:    Germany, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013

Exhibit 4-33:    Italy, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013

Exhibit 4-34:    Spain, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013

Exhibit 4-35:    United Kingdom, In Vitro Diagnostic Near-Patient Coagulation Testing Products, Market Forecast, 2008-2013

Exhibit 4-36:    2008, Europe, In Vitro Diagnostic Near-Patient Coagulation Testing Products Market, Share by Supplier

Exhibit 4-37:    Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Combined Market Forecast, 2008-2013

Exhibit 4-38:    Europe, Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products, Market Forecast, by Country, 2008-2013

 

5. COMPANY PROFILES

5.1 Abbott Laboratories

5.2 Accumetrics, Inc.

5.3 Cardiac Science Corporation

5.4 GE Healthcare, Inc./General Electric Company

5.5 International Technidyne Corporation/Thoratec Corporation

5.6 Inverness Medical Innovations, Inc.

5.7 Medtronic, Inc.

5.8 Nanogen, Inc.

5.9 Philips Healthcare/Royal Philips Electronics NV

5.10 Roche Diagnostics/F. Hoffmann La-Roche LTD/Roche Group

5.11 Siemens Healthcare Diagnostics/Siemens AG

5.12 Welch Allyn

 

APPENDIX COMPANY LISTING

 

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home